Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 950-112-7 | CAS number: 347377-00-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2019-07-31 - 2019-08-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442B (Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OCSPP 870.2600
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA): BrdU-ELISA
Test material
- Reference substance name:
- 2,4-Hexadienoic acid, 1,1’-[2-ethyl-2-[[(1-oxo-2,4-hexadien-1-yl)oxy]methyl]-1,3-propanediyl] ester
- EC Number:
- 950-112-7
- Cas Number:
- 347377-00-8
- Molecular formula:
- C24H32O6
- IUPAC Name:
- 2,4-Hexadienoic acid, 1,1’-[2-ethyl-2-[[(1-oxo-2,4-hexadien-1-yl)oxy]methyl]-1,3-propanediyl] ester
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Jackson Laboratories, Bar Harbor, ME
- Age at study initiation: Approx. 1-2 months
- Weight at study initiation: 19.0 - 21.4 g (screen animals); 18.3 -24.5 g (main animals); The weight variation of the animals at study start did not exceed ± 20% of the mean body weight in each phase.
- Housing: 1/cage in suspended wire-bottom cages during the study. Bedding was placed beneath the cages and changed at least three times per week
- Diet (e.g. ad libitum): Fresh PMI Rodent Chow (Diet #5002) ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
thirty-one nulliparous, non-pregnant female mice were assigned to the test groups of the preliminary dermal irritation screen, and the main test without conscious bias.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): controlled and continuously monitored
- Humidity (%): continuously monitored
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 5%, 10%, and 25% (w/v) in acetone/olive oil (4:1 v/v; AOO
- No. of animals per dose:
- 2 animals per group (Preliminary Dermal Irritation Screen)
5 animals per group (Main Test) - Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: Test Sample was tested for solubility at 50% (w/v) in vehicle AOO
Three groups of CBA/J mice (two animals per group) were treated with increasing concentrations of the test article: 5%, 10%, and 25% (w/v) in AOO. Treatment was via topical application of the test article concentrations to the dorsum of each ear once daily for three consecutive days. The test article was spread over the entire dorsal surface of the ear using a micropipette to deliver 25 μL/ear.
Sample preparation:
250 mg of Test Sample were added to 1000 μL of AOO and mixed to yield a 25% test article formulation. 400 μL of the 25% (w/v) formulation were added to 600 μL in AOO and mixed to yield a 10% test article formulation. 500 μL of the 10% formulation were added to 500 μL in AOO and mixed to yield a 5% (w/v) test article formulation.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: animal were assigned randomly
- Criteria used to consider a positive response:
An increase in ear thickness of 25% indicates a positive dermal irritation response.
A stimulation index SI > 3 indicates a sensitizing response.
TREATMENT PREPARATION AND ADMINISTRATION:
The test article concentrations used in the main LLNA study were chosen such that the maximum concentration tested avoided both overt systemic toxicity and excessive local dermal irritation. Concentrations of 10%, 25% and 50% (w/v) were used. 500 mg of Test Sample were added to 1000 μL with AOO and mixed to yield a 50% test article formulation. 500 μL of the 50% formulation were added to 500 μL of AOO and mixed to yield a 25% (w/v) test article formulation. 400 μL of the 25% formulation were added to 600 μL in AOO and mixed to yield a 10% (w/v) test article formulation.
Five groups of CBA/J mice (5 animals per group) were treated by topical application of the test article concentrations, vehicle control or positive control in the same manner as in the screen. AOO was chosen as the vehicle, based on solubility. Historically, the AOO vehicle has produced consistent results with the positive control 25% HCA, as well as with other sensitizers and non-sensitizers. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- For each test article-treated group, the individual animal SI values along with the mean group SI and standard deviation were calculated, and ANOVA followed by the Student-Newman-Keuls test was performed to statistically compare each test article dose group to the vehicle control group. Although specified in the test guidelines, these calculations and results were not incorporated into the interpretation of the data. An SI value of 1.6 or more is the sole determinant for a positive sensitization response.
Results and discussion
- Positive control results:
- The positive control 25% HCA (alpha-Hexylcinnamaldehyde) gave positive results, i.e. an increase in ear thickness of 17.6% and a Stimulation Index of 3.2, which is greater than 1.6 and indicates a sensitizing response.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 10% (w/v)
- Parameter:
- SI
- Value:
- 0.7
- Test group / Remarks:
- 25% (w/v)
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 50% (w/v)
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The skin sensitizing potential of the test item was determined in a well-documented guideline study compliant to GLP. Therefore, it can be considered as reliable without restrictions (Reliability 1) and the obtained results can be used for classification.
Topical application of Test Sample at 10%, 25%, and 50% (w/v) resulted in SI values that were less than 1.6 (SI < 1.6); therefore, the test article was not a dermal sensitizer in the Local Lymph Node Assay in Mice. - Executive summary:
The purpose of this GLP study was to determine the sensitizing potential of topically applied test articles. This LLNA protocol, utilizing the BrdU ELISA method, was designed to be a stand-alone assay for dermal sensitization as described in the NIH report “The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds,” NIH No. 99-4494, and the LLNA test guidelines as defined in EPA OCSPP 870.2600 and OECD Guideline for the Testing of
Chemicals No. 442B.
The results of this preliminary screen indicated that none of the test article treatments resulted in significant dermal irritation. Based on these results, test article concentrations of 10%, 25% and 50% (w/v) were chosen for the main Local Lymph Node study.
The main test was conducted with five separate groups of healthy female CBA/J mice (five animals per group). Three groups were treated with increasing concentrations of the test article. A vehicle control group was treated with AOO and another group was treated with the positive control, alpha-Hexylcinnamaldehyde in AOO (25% HCA), in the exact same manner. The test article, vehicle control, and positive control solutions were administered by topical application to the dorsum of each ear, once daily for three consecutive days.
The mean SI and standard deviation were calculated for each group from the individual animal data. If any test article treatment group yielded an SI value of 1.6 or more, then the
test article was considered to be a sensitizer.
All animals survived the in-life phase of the study and were observed to be normal. There were no difficulties noted in administration of the test article or with its adherence to the dosed ears. Body weight losses (less than 2 grams) were noted but were not considered to affect the interpretation of the study. Ear thickness measurements and individual animal observations indicated that none of the test article treatments in the screen or the main test resulted in more-than-moderate local dermal irritation. No erythema was observed in any test article treatment group.
The SI of the positive control group, 25% HCA, was 3.2. The group SI values for the test article were as follows:
Test article concentration 10% (w/v) 25% (w/v) 50% (w/v) SI value 1.0 0.7 1.0 Topical application of Test Sample at 10%, 25%, and 50% (w/v) resulted in SI values that were less than 1.6 (SI < 1.6); therefore, the test article was not a dermal sensitizer in the Local Lymph Node Assay in Mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.